-
09:35
-09:55
Patient-reported outcomes (PRO) and other novel endpoints in advanced ovarian cancer
-
09:55
-10:15
Clinical care for ovarian cancer after diagnosis: surgical quality, access to high-volume centers, and optimizing surgery
-
10:15
-10:35
Immune landscape and predictive biomarkers for clear cell carcinoma
-
10:35
-10:50
Q&A

